CompanyStageLast valuationTotal raised
OOS Therapies IncPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$7.2MOOutlook Therapeutics, Inc.Outlook Therapeutics, Inc., based in New Jersey, develops an ophthalmic formulation aimed at preserving vision.Series AHealthcareLast valuationUndisclosedTotal raisedSign inOOvelle Bio Corp.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$7MPPearl Diagnostics, Inc.Won 5 federal SBIR/STTR research awards from HHS and other federal agencies.Series AHealthcareLast valuationUndisclosedTotal raised$11.2MPPillar Therapeutics, Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$14MPPluristyx Inc.Pluristyx sells iPSC cell lines and contract development services for cell and gene therapy through its panCELLa platform.Series AHealthcareLast valuationUndisclosedTotal raised$9.8MPPortal Biotechnologies, Inc.Portal Biotechnologies, Inc., founded in 2023 in Arlington, Massachusetts, develops platforms for delivering cargo into cells such as T cells and iPSCs.Series AHealthcareLast valuationUndisclosedTotal raisedSign inPPotrero Medical, Inc.Won a federal SBIR/STTR research award from HHS and other federal agencies.Series AHealthcareLast valuationUndisclosedTotal raisedSign inQQuince Therapeutics, Inc.Quince Therapeutics, Inc., founded in 2012 in South San Francisco, is a biotechnology company that raised USD 485 million in 2023.Series AHealthcareLast valuationUndisclosedTotal raisedSign inRRapalogix Health, Inc.Rapalogix Health develops mTOR-based dermatology therapeutics and professional skincare for skin aging and disease.Series AHealthcareLast valuationUndisclosedTotal raised$19.1MRREGENTIS BIOMATERIALS LTD.Regentis Biomaterials develops GelrinC, a resorbable hydrogel implant for orthopedic tissue repair and regeneration.Series AHealthcareLast valuationUndisclosedTotal raisedSign inR
Rejuvenate Bio IncRaised capital from retail investors through a Regulation Crowdfunding offering on Wefunder Portal LLC.Series AHealthcareLast valuationUndisclosedTotal raisedSign inRReprogram Biosciences, Inc.Reprogram Biosciences, based in San Carlos, California, develops cancer therapies that reprogram cancer cells into immune-like cells.Series AHealthcareLast valuationUndisclosedTotal raised$5MRRestora Medical, Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$11.5MSSensible Biotechnologies, Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$13.5MSSenti Biosciences Holdings, Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$10MSSPINEOLOGY INCSpineology Inc., founded in 1997 in St. Paul, Minnesota, makes spinal implants, including the OptiMesh expandable interbody implant.Series AHealthcareLast valuationUndisclosedTotal raisedSign inTTenNor Therapeutics (Suzhou) LtdPrivate securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$14.7MTTolerance Bio Inc.Tolerance Bio, Inc., founded in 2023 in Pennsylvania, develops thymus-based therapies for immune-mediated diseases and immune aging.Series AHealthcareLast valuationUndisclosedTotal raisedSign inTTrellis Bioscience, Inc.Won 17 federal SBIR/STTR research awards from HHS and other federal agencies.Series AHealthcareLast valuationUndisclosedTotal raisedSign inVVitanova Biomedical Inc.Private securities offering disclosed via SEC Form D.Series AHealthcareLast valuationUndisclosedTotal raised$8M